Publications by authors named "Silvia Criscuolo"

Psoriasis is a multisystemic inflammatory disease with a significant burden in terms of disability and reduced quality of life. The interrelations between disease severity, psychological well-being, and disability and/or health-related quality of life (HRQOL) of psoriatic patients are not fully understood. The aim of the study was to assess the relative role of disease severity, depressive symptoms, and insecure attachment in predicting disability and HRQOL in 105 patients with psoriasis.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to explore brain activation differences in individuals with obsessive-compulsive disorder (OCD) compared to healthy controls using fMRI and a specific statistical method known as Activation Likelihood Estimate meta-analysis.
  • - The results revealed distinct brain activation patterns: healthy controls exhibited activity in several brain areas associated with executive tasks, while OCD patients showed altered activations, particularly increased left-sided activity but hypoactivation in certain areas like the right caudate body.
  • - The findings suggest that OCD patients demonstrate a significant functional deficit in the right caudate body during executive tasks, which could be a key neural correlate of their condition.
View Article and Find Full Text PDF

Background And Aim: Psychopathy is associated with cognitive and affective deficits causing disruptive, harmful and selfish behaviour. These have considerable societal costs due to recurrent crime and property damage. A better understanding of the neurobiological bases of psychopathy could improve therapeutic interventions, reducing the related social costs.

View Article and Find Full Text PDF

A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up. We report a case treated with 50 mg long-acting risperidone administered every 14 days, who has been followed-up for three years. We studied his regional cerebral blood flow through technetium-99 m hexamethylpropyleneamine oxime single-photon emission computed tomography after two years of treatment.

View Article and Find Full Text PDF